Diagnostic Imaging Devices Market: AI-Enhanced Image Analysis, Portable Ultrasound Democratisation, and Hybrid PET/MRI to Sustain Market Expansion Through 2035

The global Diagnostic Imaging Devices market was valued at USD 26.1 billion in 2025 and is projected to reach USD 39.80 billion by 2035, advancing at a CAGR of 4.8%. The market encompasses the full breadth of medical imaging modalities: X-ray imaging systems including digital, mobile, fluoroscopy, C-arm, and dental variants; computed tomography (CT) scanners from conventional low-slice to high-slice and cone-beam configurations; magnetic resonance imaging (MRI) systems across closed, open, high-field, and ultra-high-field architectures; ultrasound systems including 2D, 3D/4D, Doppler, contrast-enhanced, portable handheld, and cart-based platforms; nuclear imaging systems spanning PET, SPECT, PET/CT, PET/MRI, and hybrid SPECT/CT; mammography systems; imaging software and informatics including PACS, RIS, and AI-based image analysis; and contrast media and imaging accessories.

Three structural forces are reshaping diagnostic imaging: first, AI-driven image analysis tools that augment radiologist throughput and flag critical findings in CT, MRI, and chest X-ray workflows are transitioning from academic pilot programmes to commercial deployment within radiology information ecosystems at scale. Second, point-of-care portable and handheld ultrasound devices have collapsed the cost and complexity barrier sufficiently that emergency physicians, intensivists, and rural practitioners now routinely deploy ultrasound at the bedside without radiology department involvement. Third, photon-counting CT detector technology is beginning to displace conventional energy-integrating CT detectors in premium scanner installations, delivering higher spatial resolution and material decomposition capability that improves lesion characterisation without dose escalation.

Executive Snapshot

How is AI-based image analysis transforming radiology department throughput and diagnostic accuracy?
AI algorithms trained on large annotated imaging datasets and embedded within PACS and RIS workflows now perform real-time detection and triage of time-critical findings including intracranial haemorrhage, pulmonary embolism, pneumothorax, and critical bone fractures, generating automated worklist prioritisation alerts that route positive studies to radiologist review ahead of routine work. Deployment across high-volume radiology departments has reduced time-to-physician-notification for critical imaging findings from hours to minutes in published implementation studies, while sensitivity metrics for AI detection of common incidental findings including pulmonary nodules and incidental adrenal lesions have exceeded average radiologist performance in controlled evaluation studies.

What is driving the transition from energy-integrating to photon-counting CT detector technology?
Photon-counting CT detectors that count individual X-ray photons and record their energy level — rather than integrating all energy deposited over a measurement interval — eliminate electronic noise below the lowest photon energy threshold, enabling spatial resolution improvement from approximately 0.5 mm to 0.2 mm isotropic voxel size and enabling multi-energy spectral decomposition into material-specific images without radiation dose penalty. Clinical applications in cardiovascular plaque characterisation, renal stone composition analysis, and iodine quantification in oncologic imaging benefit particularly from photon-counting CT capabilities, and scanner manufacturers are progressively extending photon-counting detector availability from premium flagship models into broader scanner families.

How has handheld and portable ultrasound changed point-of-care clinical practice?
Handheld ultrasound devices connecting to smartphones or tablets via wireless or direct USB interface, priced between USD 2,000 and 8,000 versus USD 30,000 to 100,000 for traditional cart-based systems, have enabled routine point-of-care ultrasound use by emergency physicians, intensivists, anaesthesiologists, and general practitioners. Published adoption data from emergency departments indicate that focused ultrasound assessment for pneumothorax, pericardial effusion, abdominal aortic aneurysm, and deep vein thrombosis reduces time to diagnosis and time to treatment decision relative to traditional imaging order and transport workflows.

What distinguishes PET/MRI hybrid systems from PET/CT in clinical and research applications?
PET/MRI systems acquiring simultaneous PET metabolic data and MRI soft-tissue anatomical and functional data eliminate sequential scan registration errors and reduce ionising radiation exposure by replacing the CT component with MRI anatomical localisation. Clinical advantages are most pronounced in paediatric oncology — where radiation dose reduction has particular long-term significance — neurological disorders where MRI provides superior cortical and white-matter characterisation, and prostate cancer staging where MRI outperforms CT in local staging accuracy. Research applications in neuroscience and cardiology benefit from simultaneous acquisition of metabolic, perfusion, and structural MRI data in a single scan session.

How are imaging informatics platforms evolving beyond storage and retrieval toward active diagnostic decision support?
Modern imaging informatics platforms integrating PACS, RIS, AI result overlays, clinical decision support algorithms, and enterprise reporting analytics are evolving from passive image archiving into active diagnostic workflow management systems. Unified imaging platforms that aggregate AI algorithm outputs from multiple vendors into a single radiologist interface, track algorithm performance against radiologist sign-off decisions, and generate department-level quality metrics are displacing siloed single-AI-vendor deployments at large radiology operations.

Which application areas within diagnostic imaging are growing the fastest?
Cardiac CT for coronary artery calcium scoring and CT angiography driven by preventive cardiology programmes, breast tomosynthesis adoption displacing conventional 2D mammography at screening programmes, ultra-high-field 7T MRI expanding neurological research applications, and handheld ultrasound proliferating across primary care and rural health settings are the four fastest-growing application segments within the diagnostic imaging devices market.

Market Dynamics: Diagnostic Imaging Devices Market

  • AI image analysis tools reducing radiologist time-to-critical-finding notification and augmenting detection sensitivity above unaided radiologist baseline in high-volume screening programmes.
    AI-assisted radiology workflow tools accelerating critical finding triage and sustaining adoption at high-volume radiology departments managing CT, MRI, and chest X-ray workloads.
  • Photon-counting CT detector technology enabling 0.2 mm isotropic resolution and spectral material decomposition without dose increase, displacing energy-integrating detectors in premium scanner installations.
    Photon-counting CT technology sustaining premium scanner replacement investment at advanced radiology and cardiac imaging centres requiring high-resolution and spectral capability.
  • Handheld and portable ultrasound democratising bedside imaging across emergency medicine, anaesthesia, and primary care beyond traditional radiology department infrastructure.
    Point-of-care portable ultrasound expanding the addressable diagnostic imaging market into bedside clinical settings previously unserved by conventional imaging systems.
  • PET/MRI hybrid systems expanding simultaneous metabolic and structural imaging in paediatric oncology, neurology, and cardiac imaging applications above PET/CT capability.
    PET/MRI adoption growing in paediatric and neurological imaging where radiation dose reduction and superior soft-tissue contrast provide clinical advantages above PET/CT.
  • Breast tomosynthesis progressively replacing conventional 2D mammography as the standard of care at organised screening programmes across North America and Europe.
    3D mammography displacing 2D screening at organised breast cancer detection programmes, sustaining capital replacement investment at mammography facility networks.
  • Unified imaging informatics platforms aggregating multi-vendor AI algorithm outputs into single radiologist workflow interfaces displacing siloed AI deployments.
    Enterprise imaging informatics platforms integrating AI triage, PACS, and reporting analytics sustaining software and subscription revenue growth above hardware replacement cycles.

Market Segmentation: Diagnostic Imaging Devices Market

By Technology
  • Digital Imaging
  • Analog Imaging
  • AI-Assisted Imaging
  • Hybrid Imaging
  • Contrast-Enhanced Imaging
  • Molecular Imaging
By Portability
  • Stationary Systems
  • Mobile Systems
  • Portable Systems
  • Handheld Systems
By End User
  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Academic & Research Institutes
  • Other End Users
By Product Type
  • X-ray Imaging Systems
    • Digital X-ray Systems
    • Analog X-ray Systems
    • Mobile X-ray Systems
    • Fluoroscopy Systems
    • C-Arm Imaging Systems
    • Dental X-ray Systems
  • Computed Tomography (CT) Systems
    • Conventional CT Scanners
      • Low-Slice CT
      • Mid-Slice CT
      • High-Slice CT
    • Cone-Beam CT (CBCT)
    • Portable CT Scanners
  • Magnetic Resonance Imaging (MRI) Systems
    • Closed MRI Systems
    • Open MRI Systems
    • High-Field MRI Systems
    • Low-to-Mid Field MRI Systems
    • Ultra-High Field MRI Systems
  • Ultrasound Systems
    • 2D Ultrasound
    • 3D/4D Ultrasound
    • Doppler Ultrasound
    • Contrast-Enhanced Ultrasound
    • Portable/Handheld Ultrasound
    • Cart-Based Ultrasound
  • Nuclear Imaging Systems
    • PET Systems
    • SPECT Systems
    • PET/CT Systems
    • PET/MRI Systems
    • Hybrid SPECT/CT Systems
  • Mammography Systems
    • Digital Mammography
    • Breast Tomosynthesis (3D Mammography)
    • Contrast-Enhanced Mammography
  • Imaging Software & Informatics
    • PACS
    • RIS
    • AI-Based Image Analysis
    • Visualization & Post-Processing Software
  • Contrast Media & Accessories
    • CT Contrast Agents
    • MRI Contrast Agents
    • Ultrasound Contrast Agents
    • Nuclear Imaging Radiopharmaceuticals
    • Imaging Accessories & Consumables
By Application
  • X-ray Imaging
    • General Radiography
    • Dental Imaging
    • Fluoroscopy
    • Orthopedic Imaging
    • Chest Imaging
    • Trauma Imaging
  • MRI
    • Brain & Neurological Imaging
    • Spine & Musculoskeletal Imaging
    • Vascular Imaging
    • Pelvic & Abdominal Imaging
    • Breast Imaging
    • Cardiac Imaging
  • Ultrasound
    • General Imaging
    • Obstetrics & Gynecology
    • Cardiology
    • Vascular Imaging
    • Urology
    • Emergency & Critical Care
    • Other Applications
  • CT Imaging
    • Cardiology
    • Oncology
    • Neurology
    • Trauma
    • Pulmonology
    • Other Applications
  • Nuclear Imaging
    • Oncology
    • Cardiology
    • Neurology
    • Endocrinology
    • Other Applications
  • Mammography
    • Breast Cancer Screening
    • Diagnostic Breast Imaging
By Modality
  • Computed Tomography (CT)
    • Conventional CT
      • Low-Slice
      • Mid-Slice
      • High-Slice
    • Cone-Beam CT
  • Ultrasound
    • By Technology
      • 2D Ultrasound
      • 3D/4D Ultrasound
      • Doppler Ultrasound
      • Contrast-Enhanced Ultrasound
    • By Portability
      • Cart-Based Systems
      • Compact/Handheld Systems
  • X-ray Imaging
    • By Type
      • Digital X-ray
      • Analog X-ray
    • By Portability
      • Stationary Systems
      • Portable Systems
  • Magnetic Resonance Imaging (MRI)
    • By Architecture
      • Closed MRI
      • Open MRI
    • By Field Strength
      • Low-to-Mid Field MRI
      • High-Field MRI
      • Ultra-High Field MRI
  • Nuclear Imaging
    • PET
    • SPECT
    • PET/CT
    • PET/MRI
    • Hybrid SPECT/CT
  • Mammography
    • Digital Mammography
    • Breast Tomosynthesis
By Geography
  • North America: United States, Canada, and Mexico
  • Europe:  Germany, U.K., France, Italy, Spain, Russia, Benelux, Nordics, and Rest of Europe
  • Asia Pacific: China, Japan, India, South Korea, Australia, New Zealand, Taiwan, South East Asia, and Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Columbia, Chile, Peru, and Rest of Latin America
  • Middle East: Saudi Arabia, United Arab Emirates, Oman, Qatar, and Rest of Middle East
  • Africa: Nigeria, Egypt, Ethiopia, South Africa, and Rest of Africa

Key Growth Drivers: Diagnostic Imaging Devices Market

  1. AI-powered radiology tools compressing critical-finding notification time from hours to minutes and augmenting radiologist diagnostic accuracy across CT, MRI, and chest X-ray workflows.
    AI radiology tools sustaining software and professional services revenue growth at radiology department scale above imaging hardware replacement cycles.
  2. Photon-counting CT delivering superior spatial resolution and spectral decomposition capability, sustaining premium scanner replacement investment at advanced imaging centres.
    Photon-counting CT technology sustaining above-standard-CT-replacement-cycle capital investment at cardiac and oncology imaging centres adopting next-generation scanner capability.
  3. Point-of-care handheld ultrasound expanding the addressable imaging market into emergency, anaesthesia, and primary care settings beyond traditional radiology infrastructure.
    Handheld ultrasound proliferating across emergency departments, ICUs, and rural primary care settings expanding imaging procedure volumes beyond radiology department infrastructure.
  4. Breast tomosynthesis displacing 2D mammography as the organised screening standard, driving capital replacement investment at national and regional breast cancer screening programmes.
    3D mammography adoption sustaining capital replacement investment at mammography screening programme facilities across North America and Western Europe.
  5. PET/MRI hybrid adoption in paediatric oncology and neurological imaging where radiation dose reduction and superior soft-tissue contrast provide clinical advantages above PET/CT.
    PET/MRI adoption growing at paediatric and neurological imaging centres where dose reduction and simultaneous metabolic and structural MRI acquisition justify premium system investment.
  6. Unified enterprise imaging informatics aggregating AI outputs, PACS, and reporting analytics sustaining software revenue growth above imaging hardware cycles.
    Enterprise imaging platform software and subscription revenue growing above hardware replacement cycles from AI integration and cross-departmental analytics capability.

Regional Outlook: Diagnostic Imaging Devices Market

  • North America: The largest diagnostic imaging devices market, underpinned by high CT and MRI scan volumes per capita, organised mammography screening programmes driving tomosynthesis adoption, rapid AI radiology tool deployment at large health system radiology networks, and photon-counting CT early adoption at academic medical imaging centres. The U.S. FDA 510(k) clearance pathway for AI imaging tools has enabled rapid commercial deployment of algorithm portfolios.
  • Europe: Germany, France, the UK, and the Benelux countries anchor European diagnostic imaging demand. European public health system radiology departments are significant adopters of AI worklist prioritisation tools under EU medical device AI regulatory frameworks. Breast screening programmes across Scandinavia and the Netherlands have high tomosynthesis penetration rates and sustain capital replacement investment.
  • Asia-Pacific: The fastest-growing regional diagnostic imaging market, driven by China expanding hospital imaging infrastructure, India growing private diagnostic imaging centre networks in tier-1 and tier-2 cities, Japan sustaining high per-capita MRI and CT utilisation, and South Korea maintaining advanced imaging capability at Samsung and Asan Medical Centre networks. Portable ultrasound is growing fastest in rural India and Southeast Asia where access to traditional imaging infrastructure is limited.

Competitive Landscape: Diagnostic Imaging Devices Market

Key Players: GE HealthCare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Hitachi Healthcare, Shimadzu Medical, Mindray Medical, Sonosite (Fujifilm), Butterfly Network, GE HealthCare (Point-of-Care Ultrasound), Bard Diagnostics, Agfa HealthCare, Fujifilm Healthcare, Bracco Imaging (Contrast Media), Bayer Radiology (Contrast Media), Guerbet Group, Nano-X Imaging, Intelerad (Imaging Informatics)

  • Siemens Healthineers confirmed commercial availability of the NAEOTOM Alpha photon-counting CT scanner across European and North American hospital systems following initial launch installations, with Siemens reporting that NAEOTOM Alpha installations at academic medical centres are demonstrating sub-0.2 mm isotropic voxel resolution in coronary CTA protocols and enabling virtual monoenergetic spectral reconstructions that reduce contrast agent volumes by up to 40 percent compared with conventional energy-integrating CT at equivalent diagnostic image quality.
  • Butterfly Network reported expansion of its iQ3 handheld ultrasound transducer into primary care physician practice settings following U.S. CMS reimbursement clarifications covering physician-performed point-of-care ultrasound in office settings, with the company noting that primary care and internal medicine practitioners represent the fastest-growing new user segment for handheld ultrasound above the established emergency medicine and critical care user base that drove initial iQ adoption.
  • GE HealthCare announced commercial launch of its AIRx automated brain MRI protocol planning AI tool integrated within the Signa MRI scanner platform, which automatically identifies patient head position in scout images and generates exam-specific slice prescription and protocol parameters without technologist manual alignment, reducing MRI brain examination setup time by an average of 4 minutes per scan and improving cross-examination slice consistency at multi-site imaging networks with variable technologist experience levels.

Consultant POV

The Diagnostic Imaging Devices market path to USD 39.80 billion by 2035 at 4.8% CAGR is underpinned by the convergence of AI-driven image analysis elevating radiologist throughput, photon-counting CT redefining premium scanner capability, and point-of-care ultrasound expanding imaging access beyond institutional radiology infrastructure. Siemens Healthineers photon-counting CT commercial expansion, Butterfly Network primary care handheld ultrasound growth, and GE HealthCare AIRx MRI automation deployment confirm that innovation-driven volume and value expansion will sustain above-broader-healthcare-sector growth through 2035.

About Constancy Researchers Private Limited

Constancy Researchers is a global market intelligence and strategic advisory firm helping organizations navigate complex markets and make high-impact decisions with confidence. In an environment defined by rapid technological change, shifting demand patterns, and evolving competitive dynamics, we provide clarity where it matters most—at the point of decision-making. By combining deep industry understanding, rigorous analytics, and structured thinking, we enable leadership teams to identify opportunities, mitigate risks, and build strategies that drive sustainable growth.

Speak with an Analyst

    Download TOC